Cargando…
Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
Alzheimer’s disease remains a prevailing neurodegenerative condition which has an array physical, emotional, and financial consequences to patients and society. In the past decade, there has been a greater degree of investigation on therapeutic small peptides. This group of biomolecules have a profi...
Autores principales: | Singh, Som, Yang, Felix, Sivils, Andy, Cegielski, Victoria, Chu, Xiang-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312829/ https://www.ncbi.nlm.nih.gov/pubmed/35883551 http://dx.doi.org/10.3390/biom12070996 |
Ejemplares similares
-
Transient Receptor Potential (TRP) Channels in Pain, Neuropsychiatric Disorders, and Epilepsy
por: Yang, Felix, et al.
Publicado: (2023) -
Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment
por: Corrigan, Rachel R., et al.
Publicado: (2022) -
Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020) -
γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022) -
Author Correction: Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
por: Mousa, Youssef M., et al.
Publicado: (2020)